A novel protein ‐based prognostic signature improves risk stratification to guide clinical management in early‐stage lung adenocarcinoma patients
The Journal of Pathology, EarlyView.
Source: The Journal of Pathology - Category: Pathology Authors: Elena
Mart ínez‐Terroba
,
Carmen
Behrens
,
Fernando J
de Miguel
,
Jackeline
Agorreta
,
Eduard
Monsó
,
Laura
Millares
,
Cristina
Sainz
,
Miguel
Mesa‐Guzman
,
José Luis
Pérez‐Gracia
,
María Dolores
Lozano
,
Source Type: research
More News: Adenocarcinoma | Pathology